Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Korea

NACompletedINTERVENTIONAL
Enrollment

358

Participants

Timeline

Start Date

October 30, 2020

Primary Completion Date

June 2, 2024

Study Completion Date

June 2, 2024

Conditions
Advanced Heart Failure
Interventions
DEVICE

HeartMate 3™ left ventricular assist system (HM3 LVAS)

Advanced heart failure patients will be implanted with the HM3 LVAS

Trial Locations (22)

726

Incheon Sejong Hospital, Incheon

58128

Chonnam National University Hospital (CNUH), Gwangju

Unknown

Korea University Ansan Hospital, Ansan

Sejong Hospital, Bucheon-si

Pusan National University Hospital, Busan

Gyeongsang National University Changwon Hospital, Changwon

Keimyung University Dongsan Medical Center, Daegu

Kyungpook National University Hospital, Daegu

Chungnam National University Hospital, Daejeon

Hallym University Dongtan Sacred Heart Hospital, Hwaseong

Hallym University Sacred Heart Hospital, Hwaseong

Seoul National University Hospital, Ihwa-dong

Gachon University Gil Hospital, Incheon

Seoul National University Bundang Hospital, Seongnam-si

Asan Medical Center, Seoul

Gangnam Severance Hospital, Seoul

Korea University Anam Hospital, Seoul

Samsung Medical Center, Seoul

Seoul St. Mary's Hospital, Seoul

Severance Hospital, Yonsei University Health System, Seoul

St. Mary's Hospital, The Catholic University of Eunpyeong, Seoul

Pusan National University Yangsan Hospital, Yangsan

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY